How new health care technology is used—and where care is delivered—affect reimbursement as well as product adoption. Through solid working relationships with our contacts, who represent both public and private sectors, Lash Group can assemble and effectively facilitate payer and provider advisory panels to examine the reimbursement environment for such innovations. Having their opinions and perspectives enables us to evaluate the financial impact of these new products and develop strategies to enhance their adoption and utilization.